Cardlytics, Inc. (NASDAQ:CDLX) Receives Average Recommendation of “Hold” from Brokerages

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) has been assigned an average rating of “Hold” from the seven research firms that are currently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, five have given a hold recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $6.42.

Several analysts have issued reports on CDLX shares. Lake Street Capital cut their price objective on Cardlytics from $5.00 to $3.00 and set a “hold” rating on the stock in a research note on Thursday, March 13th. Evercore ISI reduced their target price on shares of Cardlytics from $4.00 to $3.00 and set an “in-line” rating for the company in a research note on Thursday, March 13th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research note on Thursday, March 13th.

Read Our Latest Research Report on CDLX

Insider Activity at Cardlytics

In other news, CEO Amit Gupta sold 46,857 shares of the business’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $159,313.80. Following the sale, the chief executive officer now owns 418,637 shares in the company, valued at $1,423,365.80. The trade was a 10.07 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Alexis Desieno sold 24,778 shares of the stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $84,245.20. Following the completion of the sale, the chief financial officer now owns 140,948 shares of the company’s stock, valued at $479,223.20. The trade was a 14.95 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 90,172 shares of company stock valued at $313,759 over the last ninety days. Insiders own 4.40% of the company’s stock.

Hedge Funds Weigh In On Cardlytics

A number of hedge funds have recently modified their holdings of CDLX. Tallon Kerry Patrick bought a new stake in shares of Cardlytics in the 4th quarter valued at approximately $37,000. ProShare Advisors LLC bought a new stake in Cardlytics in the 4th quarter valued at $43,000. Virtu Financial LLC acquired a new stake in Cardlytics during the fourth quarter worth about $62,000. BNP Paribas Financial Markets grew its holdings in shares of Cardlytics by 32.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 19,745 shares of the company’s stock worth $63,000 after purchasing an additional 4,796 shares in the last quarter. Finally, SG Americas Securities LLC increased its holdings in Cardlytics by 38.2% in the 4th quarter. SG Americas Securities LLC now owns 19,490 shares of the company’s stock valued at $72,000 after buying an additional 5,392 shares during the period. 68.10% of the stock is owned by institutional investors and hedge funds.

Cardlytics Stock Down 4.7 %

CDLX stock opened at $1.41 on Tuesday. The company has a market capitalization of $73.44 million, a P/E ratio of -0.23 and a beta of 1.39. The firm has a 50 day simple moving average of $2.33 and a 200-day simple moving average of $3.21. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. Cardlytics has a twelve month low of $1.22 and a twelve month high of $15.89.

Cardlytics Company Profile

(Get Free Report

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Recommended Stories

Analyst Recommendations for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.